These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7091299)

  • 1. Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.
    Orr FW; Mokashi S; Delikatny J
    Am J Pathol; 1982 Jul; 108(1):112-8. PubMed ID: 7091299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
    Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
    Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of intravenously injected tumor cells in the rat mesentery after intraperitoneal administration of chemotactic stimuli.
    Orr FW; Lam WC; Delikatny EJ; Mokashi S; Varani J
    Invasion Metastasis; 1981; 1(4):239-47. PubMed ID: 7188388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial characterization of a bone-derived chemotactic factor for tumor cells.
    Orr FW; Varani J; Gondek MD; Ward PA; Mundy GR
    Am J Pathol; 1980 Apr; 99(1):43-52. PubMed ID: 7361862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of passage, growth phase, and heterogeneity of a tumor cell population on tumor cell chemotaxis.
    Oda D; Orr FW
    Invasion Metastasis; 1984; 4(4):189-97. PubMed ID: 6533092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neutrophil-mediated pulmonary endothelial injury on the localization and metastasis of circulating Walker carcinosarcoma cells.
    Orr FW; Warner DJ
    Invasion Metastasis; 1987; 7(3):183-96. PubMed ID: 3596984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
    Orr W; Varani J; Ward PA
    Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo.
    Soares FA; Shaughnessy SG; MacLarkey WR; Orr FW
    Lab Invest; 1994 Oct; 71(4):480-9. PubMed ID: 7967504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor].
    Kato H; Kondo Y; Tanigawa M; Kin R; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3251-5. PubMed ID: 3777961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
    Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the C5-derived chemotactic factor for tumor cells.
    Romualdez AG; Ward PA
    Prog Clin Biol Res; 1976; 9():65-71. PubMed ID: 193134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a novel C5 inhibitor (K-76 COONa) on tumor cell chemotaxis.
    Bumpers HL; Baum J
    J Lab Clin Med; 1983 Sep; 102(3):421-7. PubMed ID: 6886523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a fibroblast chemotactic factor in serum by activation of complement.
    Postlethwaite AE; Snyderman R; Kang AH
    J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammatory process caused by intraperitoneal injection of polyester in the rat: chemotactic activity in lavage fluid from the cavity].
    Ventrelli I; Melandri P; Torboli M; Berti G; Simoni M; Sapigni T
    Boll Soc Ital Biol Sper; 1991 Jan; 67(1):89-96. PubMed ID: 1888477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotactic response of tumor cells. A model for cancer metastasis.
    Lam WC; Delikatny EJ; Orr FW; Wass J; Varani J; Ward PA
    Am J Pathol; 1981 Jul; 104(1):69-76. PubMed ID: 7258297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
    Shingu M; Nobunaga M
    Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo production of chemotactic inhibitors by tumor cells.
    Cohen MC; Brozna JP; Ward PA
    Am J Pathol; 1979 Mar; 94(3):603-14. PubMed ID: 106732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U; Dickey B; Varani J; Kreutzer DL
    J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.